“Correlation Of Tacrolimus Through Blood Levels To Rejection And Adverse Events After Kidney Transplantation”. In American Transplant Congress. American Transplant Congress. Seattle, Washington. http://onlinelibrary.wiley.com/doi/10.1111/j.1600-6135.2005.abstracts.x/pdf.
. 2005. “The Influence Of Immunomodulatory Diets On Transplant Success And Complications”. Transplantation 79. Transplantation: 460-465. http://www.ncbi.nlm.nih.gov/pubmed/15729173.
. 2005. “A Randomized, Prospective, Multicenter Comparison Of Tacrolimus, Mycophenolate Mofetil (Mmf) And Steroids Vs Cyclosporine Microemulsion, Mmf And Steroids Vs Tacrolimus, Sirolimus And Steroids In De Novo Cardiac Transplant Recipients - 12 Month Report”. In International Society For Heart And Lung Transplantation. International Society For Heart And Lung Transplantation. Philadelphia, PA. http://www.ishlt.org/meetings/pastAnnualMeetings.asp.
. 2005. “Acute Rejection Characteristics From A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Of Early Corticosteroid Withdrawal”. Transplantation 95. Transplantation: 573-579. http://www.ncbi.nlm.nih.gov/pubmed/23423269.
. 2013. “Effect Of Corticosteroid Withdrawal On Tacrolimus And Mycophenolate Mofetil Exposure In A Randomized Multicenter Study”. Am J Transplant 13. Am J Transplant: 474-484. http://www.ncbi.nlm.nih.gov/pubmed/23167508.
. 2013. “Interleukin-2 Receptor Antagonist Therapy Leads To Increased Tacrolimus Levels After Kidney Transplantation”. Ther Drug Monit 37. Ther Drug Monit: 206-213. http://www.ncbi.nlm.nih.gov/pubmed/25162212.
. 2015. “New-Onset Diabetes After Transplantation: Results From A Double-Blind Early Corticosteroid Withdrawal Trial”. Am J Transplant 15. Am J Transplant: 1982-1990. http://www.ncbi.nlm.nih.gov/pubmed/25881802.
. 2015.